AIA
Allied Investment Advisors’s Pfizer PFE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.02M | Buy |
330,727
+26,843
| +9% | +$651K | 1.4% | 36 |
|
2025
Q1 | $7.7M | Buy |
303,884
+41,147
| +16% | +$1.04M | 1.46% | 35 |
|
2024
Q4 | $6.97M | Buy |
262,737
+3,534
| +1% | +$93.8K | 1.4% | 35 |
|
2024
Q3 | $7.5M | Buy |
259,203
+9,223
| +4% | +$267K | 1.49% | 35 |
|
2024
Q2 | $6.99M | Buy |
249,980
+22,733
| +10% | +$636K | 1.64% | 34 |
|
2024
Q1 | $6.31M | Buy |
227,247
+44,351
| +24% | +$1.23M | 1.52% | 33 |
|
2023
Q4 | $5.27M | Buy |
182,896
+8,121
| +5% | +$234K | 1.43% | 33 |
|
2023
Q3 | $5.8M | Buy |
174,775
+10,723
| +7% | +$356K | 1.73% | 31 |
|
2023
Q2 | $6.02M | Buy |
164,052
+7,404
| +5% | +$272K | 1.74% | 33 |
|
2023
Q1 | $6.39M | Buy |
156,648
+6,618
| +4% | +$270K | 1.98% | 32 |
|
2022
Q4 | $7.69M | Buy |
150,030
+2,908
| +2% | +$149K | 2.4% | 19 |
|
2022
Q3 | $6.44M | Buy |
147,122
+3,795
| +3% | +$166K | 2.4% | 22 |
|
2022
Q2 | $7.52M | Buy |
143,327
+415
| +0.3% | +$21.8K | 2.7% | 11 |
|
2022
Q1 | $7.4M | Buy |
142,912
+6,052
| +4% | +$313K | 2.41% | 20 |
|
2021
Q4 | $8.08M | Buy |
136,860
+3,933
| +3% | +$232K | 2.77% | 10 |
|
2021
Q3 | $5.72M | Buy |
132,927
+2,717
| +2% | +$117K | 2.16% | 26 |
|
2021
Q2 | $5.1M | Buy |
+130,210
| New | +$5.1M | 1.92% | 31 |
|
2018
Q2 | – | Sell |
-5,885
| Closed | -$209K | – | 48 |
|
2018
Q1 | $209K | Sell |
5,885
-128
| -2% | -$4.55K | 0.17% | 46 |
|
2017
Q4 | $218K | Buy |
+6,013
| New | +$218K | 0.18% | 44 |
|